POSITION
Co-Investor
BOARD
Member & Interim CEO
EXIT
Acquired by Odan Laboratories Ltd. in December 2020
Ilkos Therapeutic Inc., is a Laval - based biopharmaceutical company incepted by CTI Life Sciences Fund II in collaboration with Laboratoires Servier (France) and FSTQ. Ilkos obtained a worldwide and exclusive licence from Laboratoires Servier for its novel clinical stage compound, S42909, indicated for the oral treatment of venous lower limb ulcers. The company was acquired by Odan Laboratories Ltd. in December 2020.